159 related articles for article (PubMed ID: 22889613)
1. A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.
Papaneri AB; Wirblich C; Cann JA; Cooper K; Jahrling PB; Schnell MJ; Blaney JE
Virology; 2012 Dec; 434(1):18-26. PubMed ID: 22889613
[TBL] [Abstract][Full Text] [Related]
2. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses.
Blaney JE; Wirblich C; Papaneri AB; Johnson RF; Myers CJ; Juelich TL; Holbrook MR; Freiberg AN; Bernbaum JG; Jahrling PB; Paragas J; Schnell MJ
J Virol; 2011 Oct; 85(20):10605-16. PubMed ID: 21849459
[TBL] [Abstract][Full Text] [Related]
3. Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.
Papaneri AB; Bernbaum JG; Blaney JE; Jahrling PB; Schnell MJ; Johnson RF
Virus Res; 2015 Feb; 197():54-8. PubMed ID: 25481284
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.
Papaneri AB; Wirblich C; Cooper K; Jahrling PB; Schnell MJ; Blaney JE
Vaccine; 2012 Sep; 30(43):6136-41. PubMed ID: 22884661
[TBL] [Abstract][Full Text] [Related]
6. Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine.
Blaney JE; Marzi A; Willet M; Papaneri AB; Wirblich C; Feldmann F; Holbrook M; Jahrling P; Feldmann H; Schnell MJ
PLoS Pathog; 2013; 9(5):e1003389. PubMed ID: 23737747
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
9. Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge.
Kurup D; Fisher CR; Smith TG; Abreu-Mota T; Yang Y; Jackson FR; Gallardo-Romero N; Franka R; Bronshtein V; Schnell MJ
J Infect Dis; 2019 Sep; 220(9):1521-1528. PubMed ID: 31374568
[TBL] [Abstract][Full Text] [Related]
10. A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon.
Zhang YN; Chen C; Deng CL; Zhang CG; Li N; Wang Z; Zhao L; Zhang B
EBioMedicine; 2020 Jun; 56():102819. PubMed ID: 32512518
[TBL] [Abstract][Full Text] [Related]
11. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
12. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
13. Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies.
Schutsky K; Curtis D; Bongiorno EK; Barkhouse DA; Kean RB; Dietzschold B; Hooper DC; Faber M
J Virol; 2013 Feb; 87(3):1834-41. PubMed ID: 23192867
[TBL] [Abstract][Full Text] [Related]
14. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
Nakagawa K; Ito N; Masatani T; Abe M; Yamaoka S; Ito Y; Okadera K; Sugiyama M
Vaccine; 2012 May; 30(24):3610-7. PubMed ID: 22464967
[TBL] [Abstract][Full Text] [Related]
15. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
Plummer JR; McGettigan JP
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
[TBL] [Abstract][Full Text] [Related]
16. Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.
Cenna J; Hunter M; Tan GS; Papaneri AB; Ribka EP; Schnell MJ; Marx PA; McGettigan JP
J Infect Dis; 2009 Oct; 200(8):1251-60. PubMed ID: 19764884
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
[TBL] [Abstract][Full Text] [Related]
18. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
[TBL] [Abstract][Full Text] [Related]
19. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
20. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
